Steady Increase in Liver Cancer Death Rates Observed in Adults Aged 25 and Older

Tony Berberabe, MPH @OncBiz_Wiz
Published: Saturday, Sep 22, 2018
Jiaquan Xu, MD

Jiaquan Xu, MD

A National Center for Health Statistics (NCHS) briefing stratifies liver cancer mortality by sex, ethnicity, and age for adults aged 25 years and over. Overall, death rates increased significantly for both sexes, with death rates for men 2 to 2.5 times the rate for women from 2000 through 2016. The news for non-Hispanic white, non-Hispanic black, and Hispanic adults is not good, either, with increased liver cancer death rates reported for these populations. However, liver cancer deaths declined for non-Hispanic Asian or Pacific Island (API) adults during the same time period.1,2

 

Figure 1. Age-adjusted Death Rates for Liver Cancer Among Adults Aged 25 and Over, By Sex: United States, 2000-2016

Age-adjusted Death Rates for Liver Cancer Among Adults Aged 25 and Over, By Sex: United States, 2000-2016

 



 

Figure 2. Age-Adjusted Death Rates for Liver Cancer Among Adults Aged 25 and Older, by Race and Ethnicity: United States, 2000-2016

Age-Adjusted Death Rates for Liver Cancer Among Adults Aged 25 and Older, by Race and Ethnicity: United States, 2000-2016

 



Behind Washington, DC, age-adjusted death rates for liver cancer among adults were highest in Louisiana (13.8), Hawaii (12.7), and Mississippi and New Mexico (12.4 each) in 2016. The 5 states with the lowest age-adjusted liver cancer death rates were Vermont, Maine (7.4), Montana (7.7), and Utah and Nebraska (7.8 each).

References

  1. Xu J, Murphy SL, Kochanek KD, Bastian BA. Deaths: Final Data for 2013. Natl Vital Stat Rep. 2016 Feb 16;64(2):1-119.
  2. Xu J. Trends in liver cancer mortality among adults aged 25 and over in the United States, 2000-2016. NCHS Data Brief. 2018;(314):1-8.

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Individualizing Treatment After Second-Line Therapy for Patients With mCRCAug 29, 20191.0
Community Practice Connections™: Navigating New Sequencing Challenges for the Treatment of Hepatocellular CarcinomaAug 30, 20191.5
Publication Bottom Border
Border Publication
x